Evaluation of the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis from a societal perspective in Germany

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Koeditz D, Frensch J, Bierbaum M, Ness N-, Ettle B, Ziemssen T.

Verlag

Publisher-Information
Nervenheilkunde 2022;41(7-8):502-508.

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/20552173221085741

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2022